@ARTICLE{
author={Fleischmann Roy M|,Damjanov Nemanja S|,Kivitz Alan J|,Legedza Anna|,Hoock Thomas|,Kinnman Nils|},
year={2015},
title={A Randomized, Double-Blind, Placebo-Controlled, Twelve-Week, Dose-Ranging Study of Decernotinib, an Oral Selective JAK-3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={67},
number={2},
pages={334-343},
document_type={Article},
}